RyMat Inc.

Solution provider to the Pharmaceutical Industry. Assisting companies with projects from INDs to ANDAa and all points in between. Working with CROs & CMOs to define their offer, maximize resources, develop new business, manage ongoing projects and existing clients. Providing solutions for the outsourcing of all elements of the drug development process including Drug Delivery. In-Licensing and Out-Licensing of finished dosage & products to the pharmaceutical industry, contract inception, contract negotiation & execution, life-cycle management. Project Management from initial proposal development through commercial scale manufacturing. Focus on INDs, NDAs, 505(b)(2) NDAs, ANDAs & OTC switches. Regulatory assistance, CMC preparation, and adherence to FDA guidelines. We aim at building true and tailored collaboration models united by an innovation and outcome driven mindset and strongly focusing on the patients as we adhere to our mission ‘Science For A Better Life’. Our collaborations range from strategic alliances in basic research and the development of new technologies to concrete R&D projects in our core therapeutic areas or co-development and co-commercialization agreements. In the years to come, we plan to further extend our partnering activities and invest even more in collaboration and external innovation.